UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000035869
Receipt No. R000040850
Scientific Title Phase I and II trial of combination therapy using nab-Paclitaxel+Pertuzumab+Trastuzumab for HER2 positive metastatic breast cancer
Date of disclosure of the study information 2019/04/01
Last modified on 2019/02/13 19:23:24

No. Disposal Last modified on Item of update
1 Insert 2019/02/13 19:24:28


Contact us.